Drug Markets/Potassium Citrate

Potassium Citrate

23 NDCs across 10 manufacturers|21 Generic,2 Brand

Potassium Citrate is used to treat renal tubular acidosis, hypokalemia and lithiasis, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Aug 30, 1985, and the first generic was approved Jun 9, 2006. FDA's Orange Book lists 24 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $50 million on Potassium Citrate across 531,000 claims for 145,000 beneficiaries.

Potassium Citrate is available as 23 NDCs from 10 manufacturers (21 generic, 2 brand), with NADAC prices from $0.13 to $3.55 per EAthe most expensive product costs about 27× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

23

21G / 2B

Manufacturers

10

competing in market

Price Spread

$0.13 – $3.55

per EA

7d Activity

42-19 flat

avg -2.2% WoW · of 23 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

23 NDCs total, 23 shown

Drug Price 7d Change
UROCIT-K ER 15 MEQ TABLET
$3.5507
per EA
UROCIT-K SR 10 MEQ TABLET
$2.0855
per EA
POTASSIUM CITRATE ER 15 MEQ TB
$0.1804
per EA
-0.83%
POTASSIUM CITRATE ER 15 MEQ TB
$0.1804
per EA
-0.83%
POTASSIUM CITRATE ER 15 MEQ TB
$0.1804
per EA
-0.83%
POTASSIUM CITRATE ER 15 MEQ TB
$0.1804
per EA
-0.83%
POTASSIUM CITRATE ER 15 MEQ TB
$0.1804
per EA
-0.83%
POTASSIUM CITRATE ER 15 MEQ TB
$0.1804
per EA
-0.83%
POTASSIUM CITRATE ER 10 MEQ TB
$0.1798
per EA
-0.75%
POTASSIUM CITRATE ER 10 MEQ TB
$0.1798
per EA
-0.75%
POTASSIUM CITRATE ER 10 MEQ TB
$0.1798
per EA
-0.75%
POTASSIUM CITRATE ER 10 MEQ TB
$0.1798
per EA
-0.75%
POTASSIUM CITRATE ER 10 MEQ TB
$0.1798
per EA
-0.75%
POTASSIUM CITRATE ER 10 MEQ TB
$0.1798
per EA
-0.75%
POTASSIUM CITRATE ER 10 MEQ TB
$0.1798
per EA
-0.75%
POTASSIUM CITRATE ER 10 MEQ TB
$0.1798
per EA
-0.75%
POTASSIUM CITRATE ER 10 MEQ TB
$0.1798
per EA
-0.75%
POTASSIUM CITRATE ER 5 MEQ TAB
$0.1336
per EA
-5.87%
POTASSIUM CITRATE ER 5 MEQ TAB
$0.1336
per EA
-5.87%
POTASSIUM CITRATE ER 5 MEQ TAB
$0.1336
per EA
-5.87%
POTASSIUM CITRATE ER 5 MEQ TAB
$0.1336
per EA
-5.87%
POTASSIUM CITRATE ER 5 MEQ TAB
$0.1336
per EA
-5.87%
POTASSIUM CITRATE ER 5 MEQ TAB
$0.1336
per EA
-5.87%

Frequently Asked Questions

What is Potassium Citrate used to treat?

Potassium Citrate is used to treat renal tubular acidosis, hypokalemia and lithiasis, per the National Library of Medicine's MED-RT classification.

When did Potassium Citrate become available as a generic?

FDA approved the first generic Potassium Citrate (ANDA) on Jun 9, 2006. The Orange Book currently lists 24 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Potassium Citrate?

In 2024, Medicare Part D spent $50 million on Potassium Citrate across 531,000 claims for 145,000 beneficiaries.

How many Potassium Citrate products are on the market?

The Potassium Citrate drug market contains 23 NDCs from 10 manufacturers — 21 generic and 2 brand products.

What is the price range for Potassium Citrate?

NADAC reference prices for Potassium Citrate range from $0.1336 to $3.5507 per EA — the most expensive product costs about 27× the cheapest.

Is generic Potassium Citrate cheaper than brand?

The average generic NADAC for Potassium Citrate is $0.1668 per EA, versus $2.8181 for brand-labeled products — brand versions average about 17× the generic price.

Which manufacturers make Potassium Citrate?

10 manufacturers list Potassium Citrate in NADAC. Ranked by number of NDCs, the largest are Strides Pharma Inc. (3), Actavis Pharma, Inc. (3), Zydus Pharmaceuticals (USA) Inc. (3), Camber Pharmaceuticals Inc. (3), Mission Pharmacal Company (2).

How has the price of Potassium Citrate changed recently?

Over the past 7 days, 0 Potassium Citrate NDCs rose and 42 fell, with a market-wide average change of -2.2%.